동향
Home > DB > 동향
| Heparin for Drug and Medical Device Use: Monitoring Crude | |||
|---|---|---|---|
| 분류 | GMP, Guidance | 조회 | 2812 |
| 발행년도 | 2013 | 등록일 | 2015-10-02 |
| 출처 | FDA (바로가기) | ||
|
This guidance is intended to alert manufacturers of active pharmaceutical ingredients (APIs), pharmaceutical and medical device manufacturers of finished products, repackers, and others to the potential risk of crude heparin contamination.
(후략)
|
|||
|
|
 이전글 |
Contract Manufacturing Arrangements for Drugs: Quality Agreements |
|---|---|
 다음글 |
Media Fills for Validation of Aseptic Preparations for Positron Emission Tomography |
